390 related articles for article (PubMed ID: 32460855)
1. The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
Langbaum JB; Ellison NN; Caputo A; Thomas RG; Langlois C; Riviere ME; Graf A; Lopez Lopez C; Reiman EM; Tariot PN; Hendrix SB
Alzheimers Res Ther; 2020 May; 12(1):66. PubMed ID: 32460855
[TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
[TBL] [Abstract][Full Text] [Related]
3. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
Langbaum JB; Hendrix SB; Ayutyanont N; Chen K; Fleisher AS; Shah RC; Barnes LL; Bennett DA; Tariot PN; Reiman EM
Alzheimers Dement; 2014 Nov; 10(6):666-74. PubMed ID: 24751827
[TBL] [Abstract][Full Text] [Related]
4. Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's disease.
Caputo A; Racine A; Paule I; Tariot PN; Langbaum JB; Coello N; Riviere ME; Ryan JM; Lopez CL; Graf A; ;
Alzheimers Res Ther; 2023 Mar; 15(1):45. PubMed ID: 36879340
[TBL] [Abstract][Full Text] [Related]
5. Development of a Cognitive Composite for Preclinical Alzheimer's Disease in Korean Older Adults.
Kim M; Yi D; Byun MS; Ahn H; Jung JH; Kong N; Chang Y; Choi H; Choi J; Kim K; Jung G; Lee DY;
J Alzheimers Dis; 2023; 96(2):633-641. PubMed ID: 37807780
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
[No Abstract] [Full Text] [Related]
7. Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials.
Borland E; Edgar C; Stomrud E; Cullen N; Hansson O; Palmqvist S
Neurology; 2022 Sep; 99(11):e1142-e1153. PubMed ID: 35835560
[TBL] [Abstract][Full Text] [Related]
8. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
9. The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer's Disease: A Longitudinal Study.
Rapos Pereira F; George N; Dalla Barba G; Dubois B; La Corte V;
J Alzheimers Dis; 2024; 98(2):465-479. PubMed ID: 38393903
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.
Wang D; Schultz T; Novak GP; Baker S; Bennett DA; Narayan VA
J Alzheimers Dis; 2018; 62(2):855-865. PubMed ID: 29480187
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.
Papp KV; Rofael H; Veroff AE; Donohue MC; Wang S; Randolph C; Grober E; Brashear HR; Novak G; Ernstrom K; Raman R; Aisen PS; Sperling R; Romano G; Henley D
J Prev Alzheimers Dis; 2022; 9(2):255-261. PubMed ID: 35542998
[TBL] [Abstract][Full Text] [Related]
12. Application of Digital Cognitive Biomarkers for Alzheimer's Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline.
Bock JR; Hara J; Fortier D; Lee MD; Petersen RC; Shankle WR
J Prev Alzheimers Dis; 2021; 8(2):123-126. PubMed ID: 33569557
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal amyloid cognitive composite in preclinical Alzheimer's disease.
Kim YJ; Hahn A; Park YH; Na DL; Chin J; Seo SW
Eur J Neurol; 2022 Apr; 29(4):980-989. PubMed ID: 34972256
[TBL] [Abstract][Full Text] [Related]
14. Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer's Disease.
Jutten RJ; Sikkes SAM; Amariglio RE; Buckley RF; Properzi MJ; Marshall GA; Rentz DM; Johnson KA; Teunissen CE; Van Berckel BNM; Van der Flier WM; Scheltens P; Sperling RA; Papp KV; ;
J Int Neuropsychol Soc; 2021 May; 27(5):426-438. PubMed ID: 33046162
[TBL] [Abstract][Full Text] [Related]
15. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.
Papp KV; Buckley R; Mormino E; Maruff P; Villemagne VL; Masters CL; Johnson KA; Rentz DM; Sperling RA; Amariglio RE;
Alzheimers Dement; 2020 Mar; 16(3):552-560. PubMed ID: 31759879
[TBL] [Abstract][Full Text] [Related]
16. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
[TBL] [Abstract][Full Text] [Related]
17. Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
Williams OA; An Y; Armstrong NM; Kitner-Triolo M; Ferrucci L; Resnick SM
J Alzheimers Dis; 2020; 75(4):1169-1180. PubMed ID: 32390623
[TBL] [Abstract][Full Text] [Related]
18. A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.
Guzmán-Vélez E; Jaimes S; Aguirre-Acevedo DC; Norton DJ; Papp KV; Amariglio R; Rentz D; Baena A; Henao E; Tirado V; Muñoz C; Giraldo M; Sperling RA; Lopera F; Quiroz YT
J Alzheimers Dis; 2018; 65(1):107-115. PubMed ID: 30040714
[TBL] [Abstract][Full Text] [Related]
19. Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults.
Gavett BE; Gurnani AS; Saurman JL; Chapman KR; Steinberg EG; Martin B; Chaisson CE; Mez J; Tripodis Y; Stern RA
PLoS One; 2016; 11(10):e0164492. PubMed ID: 27711147
[TBL] [Abstract][Full Text] [Related]
20. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
